INV4
3月前
Why Did IBO Stock Surge 65% In Pre-Market Today?
The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.
• Under the revised agreement, the combined public company will issue around 169.6 million ordinary shares.
• The combined public company will also issue 128,000 shares to DSS, its parent company.
• This follows a June 2025 agreement to combine Dr Ashleys’ manufacturing with Impact BioMedical’s portfolio of more than 90 medical patents.
Shares of Impact BioMedical (IBO) soared over 65% in pre-market trading on Thursday, after the company announced amendments to agreements tied to its planned merger with Dr Ashleys.
If the pre-market level holds after the opening bell, IBO stock would hit its highest since Sept. 12, 2025.
PubCo To Issue 169.6 Million Shares
Under the revised agreement, the combined public company, referred to as PubCo, will issue 169,560,000 ordinary shares, which represent about 94.2% of PubCo’s outstanding shares at the closing of the business combination. These shares are called the Company Share Consideration.
PubCo will issue 22,000 shares to Impact’s CEO, Frank D. Heuszel, and up to 128,000 shares to DSS in two batches. DSS is the parent company of Impact BioMedical. These shares will be deducted from the PubCo’s Company Share Consideration.
Additionally, the deadline to complete the merger was extended from March 31, 2026, to July 1, 2026, while shareholders who support the transaction currently control about 88.9% of Impact BioMedical’s shares.
Merger To Open Up Manufacturing Access For Impact
In June 2025, Impact BioMedical and Dr Ashleys signed a definitive merger agreement with Dr Ashleys. The transaction will create a new holding company that will own both Dr Ashleys and Impact BioMedical as subsidiaries. The combined company will be led by Dr Ashleys’ executive team and a newly appointed board.
The merger aims to combine Dr Ashleys’ manufacturing and global market access with Impact BioMedical’s portfolio of more than 90 patents covering treatments for cancer, infectious diseases, respiratory illnesses, and orphan drugs.
How Did Stocktwits Users React?
The stock garnered significant retail buzz, with Stocktwits data indicating a 14,200% increase in message volumes over the past 24 hours, while retail sentiment on the platform turned ‘extremely bullish’ from ‘bullish’ a day back.
Link article
$IBO 🗞️
JJ8
11月前
IBO Trend Analysis
IBO appears to be rallying within a longer-term bearish trend, driving its MACD above the signal line. However, shares remain below a declining 200-day moving average, signifying that the dominant trend remains lower. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
Momentum for IBO is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares.
Today's volume is on track to be lighter than usual, with 90,136 shares having traded so far. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active than sellers as of 11:57 AM ET Thursday, 07/24/2025
JJ8
12月前
Momentum for IBO is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares.
Today's volume is on track to be lighter than usual, with 15,333,257 shares having traded so far. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active than sellers.
Bollinger Bands® use standard deviation of the closing price around a moving average to measure volatility. The Bollinger Bands® are presently wider than usual, as a result of greater than normal volatility that accompanied the recent price move. Events such as this may precede a pause or reversal in the near term trend. As of 12:56 PM ET Wednesday, 06/25/2025
JJ8
12月前
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
June 23 2025 - 7:52AM
Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“Impact BioMedical”) (NYSE American: IBO), a Texas based biopharmaceuticals developer listed on the New York Stock Exchange American (“Impact BioMedical”, together with Dr Ashleys, the “Parties”), are pleased to announce the execution of a merger and share exchange agreement (the “Merger Agreement”) on June 21, 2025 to enter into a strategic merger transaction (the “Transaction”). Upon closing of the Transaction, Dr. Ashleys will acquire Impact BioMedical through a reverse merger that will result in a newly formed combined entity (the “PubCo”) traded on the NYSE American under the name “Dr Ashleys Limited.”
The Transaction marks a strategic move that underscores the growing importance of innovation and collaboration in the biomedical industry. With Dr Ashleys’ global reach and financial capabilities, the potential for Impact BioMedical’s patents to reach the market has never been greater.
JJ8
12月前
A great day for us. Congrats
I was away today and just now seeing my Port value, I jumped up in joy!
I can't believe my eyes
Happy days are here again, lol.
GLTY & GLTA
PS: Momentum for IBO is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Today's volume was heavier than usual, trading 423,133,297 shares, versus an average of 5,340,041 shares per day during the last twelve months. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active than sellers. Bollinger Bands® use standard deviation of the closing price around a moving average to measure volatility. The Bollinger Bands® are presently wider than usual, as a result of greater than normal volatility that accompanied the recent price move. Events such as this may precede a pause or reversal in the near term trend.
JJ8
1年前
Share price ASCENDING TRIPLE TOP BREAKOUT on 22-May-2025.
Based on recent history, the best would be Demand Volume forces it to
around even $6 area. It could become an interesting day.
We shall see. I should say that a too fast a price jump may not lead to a stable price level as it was the case last time. But is on best scenario in my thoughts. I am an opti-mist, lol. It all depends on the Demand Volume to make the jump first! It is not there yet. It's a process dynamic that may require time but sometime it may develop in an avalanche mode as well.
Cheers & GLTA
PS: Today's volume is on track to be heavier than usual, with 241,098 shares having traded so far. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active than sellers as of 10:50 AM ET Thursday, 05/22/2025